{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:41:09Z","timestamp":1791250869522,"version":"4.1.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To reduce acute kidney injury (AKI) associated with nephrotoxic medication (NTM) exposure in critically ill pediatric patients through a structured quality improvement (QI) initiative.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DESIGN:<\/jats:title>\n                    <jats:p>Prospective, multi-phased QI project.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>SETTING:<\/jats:title>\n                    <jats:p>A single-center, free-standing, quaternary care children\u2019s hospital.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PATIENTS:<\/jats:title>\n                    <jats:p>All patients admitted to the PICU during the study period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>INTERVENTIONS:<\/jats:title>\n                    <jats:p>A three-phase intervention strategy was implemented to increase awareness surrounding NTM exposures in PICU and their role in subsequent AKI development. Phase 1 introduced monthly pharmacist-led educational session for resident physicians. Phase 2 incorporated an informational handout reviewed during monthly resident orientations. In phase 3, clinical pharmacists provided daily notifications to attending physicians for patients meeting NTM exposure criteria, offering timely alternatives and AKI monitoring recommendations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MEASUREMENTS AND MAIN RESULTS:<\/jats:title>\n                    <jats:p>NTM exposure and NTM-associated AKI (NAKI) rates per 1000 patient-days were measured across pre-intervention and post-intervention periods. From May 1, 2021, to December 31, 2023, a total of 34,631 patient-days were included. During this period, 2410 and 388 patient-days, respectively, satisfied NTM exposure and NAKI criteria. This accounted for 1039 NTM exposure events in 742 patients and 159 NAKI episodes in 125 unique patients. Following interventions, NTM exposure rates declined from 30.6 to 26.9 per 1000 patient-days (a 12.4% reduction), and NAKI rates decreased from 5.6 to 2.5 per 1000 patient-days (a 55% reduction).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>Targeted PICU-specific interventions, including routine stakeholder education and pharmacy-driven daily provider notifications, were associated with reductions in NTM exposure and subsequent NAKI rates in critically ill patients. Efforts to integrate and sustain these strategies at the institutional level are currently in progress.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/pcc.0000000000003883","type":"journal-article","created":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T15:00:43Z","timestamp":1767106843000},"page":"187-196","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Reducing Acute Kidney Injury in Critically Ill Pediatric Patients: Quality Improvement Project Targeting Nephrotoxic Medication Exposures"],"prefix":"10.1097","volume":"27","author":[{"given":"Natalie","family":"Capretta","sequence":"first","affiliation":[{"name":"Division of Critical Care Medicine, Nationwide Children\u2019s Hospital, Columbus, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0671-4453","authenticated-orcid":false,"given":"Diana","family":"Zepeda-Orozco","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The Ohio State University College of Medicine, Columbus, OH."},{"name":"Kidney and Urinary Tract Research Center, The Abigail Wexner Research Institute at Nationwide Children\u2019s, Columbus, OH."},{"name":"Division of Nephrology, Dialysis and Hypertension, Nationwide Children\u2019s Hospital, Columbus, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Joshua","family":"Frazier","sequence":"additional","affiliation":[{"name":"Division of Critical Care Medicine, Nationwide Children\u2019s Hospital, Columbus, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Lutmer","sequence":"additional","affiliation":[{"name":"Division of Critical Care Medicine, Nationwide Children\u2019s Hospital, Columbus, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Lieb-Sargel","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Nationwide Children\u2019s Hospital, Columbus, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Muszynski","sequence":"additional","affiliation":[{"name":"Division of Critical Care Medicine, Nationwide Children\u2019s Hospital, Columbus, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay","family":"Kalata","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Administration, Nationwide Children\u2019s Hospital, Columbus, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Welty","sequence":"additional","affiliation":[{"name":"Department of Clinical Outcomes, Center for Clinical Excellence, Nationwide Children\u2019s Hospital, Columbus, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashlee","family":"Leone","sequence":"additional","affiliation":[{"name":"Department of Clinical Outcomes, Center for Clinical Excellence, Nationwide Children\u2019s Hospital, Columbus, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Gajarski","sequence":"additional","affiliation":[{"name":"The Heart Center, Department of Cardiology, Nationwide Children\u2019s Hospital, Columbus, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,12,30]]},"reference":[{"key":"R1-20260205","doi-asserted-by":"crossref","first-page":"635631","DOI":"10.3389\/fped.2021.635631","article-title":"Impact of acute kidney injury on critically ill children and neonates.","volume":"9","author":"Leghrouz","year":"2021","journal-title":"Front Pediatr"},{"key":"R2-20260205","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/MOP.0b013e328342ff37","article-title":"Evaluation and management of critically ill children with acute kidney injury.","volume":"23","author":"Askenazi","year":"2011","journal-title":"Curr Opin Pediatr"},{"key":"R3-20260205","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1741-7015-9-135","article-title":"Acute kidney injury biomarkers: Renal angina and the need for a renal troponin I.","volume":"9","author":"Goldstein","year":"2011","journal-title":"BMC Med"},{"key":"R4-20260205","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/sj.ki.5000032","article-title":"3-5 year longitudinal follow-up of pediatric patients after acute renal failure.","volume":"69","author":"Askenazi","year":"2006","journal-title":"Kidney Int"},{"key":"R5-20260205","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1053\/j.ajkd.2011.10.048","article-title":"Long-term risk of CKD in children surviving episodes of acute kidney injury in the intensive care unit: A prospective cohort study.","volume":"59","author":"Mammen","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"R6-20260205","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1007\/s00467-018-3981-8","article-title":"Risk factors and inpatient outcomes associated with acute kidney injury at pediatric severe sepsis presentation.","volume":"33","author":"Fitzgerald","year":"2018","journal-title":"Pediatr Nephrol"},{"key":"R7-20260205","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1611391","article-title":"Epidemiology of acute kidney injury in critically ill children and young adults.","volume":"376","author":"Kaddourah","year":"2017","journal-title":"N Engl J Med"},{"key":"R8-20260205","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.2215\/CJN.00270113","article-title":"AKI in hospitalized children: Epidemiology and clinical associations in a national cohort.","volume":"8","author":"Sutherland","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"R9-20260205","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/PCC.0000000000000461","article-title":"Association between progression and improvement of acute kidney injury and mortality in critically ill children.","volume":"16","author":"Sanchez-Pinto","year":"2015","journal-title":"Pediatr Crit Care Med"},{"key":"R10-20260205","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s00467-019-04431-3","article-title":"Impact of acute kidney injury and nephrotoxic exposure on hospital length of stay.","volume":"35","author":"Searns","year":"2020","journal-title":"Pediatr Nephrol"},{"key":"R11-20260205","first-page":"e19689","article-title":"Frequency of drug induced acute kidney injury in pediatric intensive care unit.","volume":"13","author":"Gowa","year":"2021","journal-title":"Cureus"},{"key":"R12-20260205","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.ccc.2015.06.005","article-title":"Drug-induced acute kidney injury: A focus on risk assessment for prevention.","volume":"31","author":"Kane-Gill","year":"2015","journal-title":"Crit Care Clin"},{"key":"R13-20260205","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.kint.2016.03.031","article-title":"A sustained quality improvement program reduces nephrotoxic medication-associated acute kidney injury.","volume":"90","author":"Goldstein","year":"2016","journal-title":"Kidney Int"},{"key":"R14-20260205","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jpeds.2019.08.046","article-title":"Baby NINJA (Nephrotoxic Injury Negated by Just-in-Time Action): Reduction of nephrotoxic medication-associated acute kidney injury in the neonatal intensive care unit.","volume":"215","author":"Stoops","year":"2019","journal-title":"J Pediatr"},{"key":"R15-20260205","doi-asserted-by":"crossref","first-page":"e28396","DOI":"10.1002\/pbc.28396","article-title":"Reducing acute kidney injury in pediatric oncology patients: An improvement project targeting nephrotoxic medications.","volume":"67","author":"Young","year":"2020","journal-title":"Pediatr Blood Cancer"},{"key":"R16-20260205","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1093\/ajhp\/zxz203","article-title":"Evidence-based development of a nephrotoxic medication list to screen for acute kidney injury risk in hospitalized children.","volume":"76","author":"Goswami","year":"2019","journal-title":"Am J Health Syst Pharm"},{"key":"R17-20260205","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1136\/bmjqs-2015-004411","article-title":"SQUIRE 2.0 (Standards for QUality Improvement Reporting Excellence): Revised publication guidelines from a detailed consensus process.","volume":"25","author":"Ogrinc","year":"2016","journal-title":"BMJ Qual Saf"},{"key":"R19-20260205","doi-asserted-by":"crossref","first-page":"e423","DOI":"10.1542\/peds.2011-3566","article-title":"Quality improvement initiative to reduce serious safety events and improve patient safety culture.","volume":"130","author":"Muething","year":"2012","journal-title":"Pediatrics"},{"key":"R20-20260205","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1136\/qhc.12.6.458","article-title":"Statistical process control as a tool for research and healthcare improvement.","volume":"12","author":"Benneyan","year":"2003","journal-title":"Qual Saf Health Care"},{"key":"R21-20260205","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1542\/peds.2021-052888J","article-title":"Renal dysfunction criteria in critically ill children: The PODIUM consensus conference.","volume":"149","author":"Fitzgerald","year":"2022","journal-title":"Pediatrics"}],"container-title":["Pediatric Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/PCC.0000000000003883","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:42:00Z","timestamp":1786034520000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/PCC.0000000000003883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,30]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/pcc.0000000000003883","relation":{},"ISSN":["1529-7535","1947-3893"],"issn-type":[{"value":"1529-7535","type":"print"},{"value":"1947-3893","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,30]]}}}